NCT01817972View on ClinicalTrials.gov

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

PHASE3UnknownINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2014

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

Certolizumab pegol

Subcutaneous injection

DRUG

Azathioprine

50mg tablets

Trial Locations (1)

78229

Gastroenterology Research of America, San Antonio

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Gastroenterology Research of America

OTHER

NCT01817972 - Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease | Biotech Hunter | Biotech Hunter